Skip to main content
Inpatient Procedure Code

3E05029 ICD-10-PCS Code: Introduction of Other Anti-infective into Peripheral Artery, Open Approach

Introduce of Oth Anti-infect into Periph Art, Open Approach

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
Section3

Administration

2
Body SystemE

Physiological Systems and Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body System / Region5

Peripheral Artery

5
Approach0

Open

6
Substance2

Anti-infective

7
Qualifier9

Other Anti-infective

Related Codes

Same operation — other Body System / Region

Same table and root operation, differing only in the body system / region character.

3E03029 — Introduction of Other Anti-infective into Peripheral Vein, Open Approach, 3E04029 — Introduction of Other Anti-infective into Central Vein, Open Approach, 3E06029 — Introduction of Other Anti-infective into Central Artery, Open Approach, 3E0Q029 — Introduction of Other Anti-infective into Cranial Cavity and Brain, Open Approach, 3E0U029 — Introduction of Other Anti-infective into Joints, Open Approach

Same operation — other Approach

Same table and root operation, differing only in the approach character.

3E05329 — Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach

Same operation — other Qualifier

Same table and root operation, differing only in the qualifier character.

3E05028 — Introduction of Oxazolidinones into Peripheral Artery, Open Approach

Same procedure category (CCSR), other tables

AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of antibiotics (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.

XW0334A — Introduction of Cefepime-taniborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW0335A — Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW03396 — Introduction of Ceftolozane/Tazobactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6, XW033K9 — Introduction of Sulbactam-Durlobactam into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW033PB — Introduction of Aztreonam-avibactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW033WB — Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW0434A — Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10, XW0435A — Introduction of Ceftobiprole Medocaril Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10, XW04396 — Introduction of Ceftolozane/Tazobactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6, XW043K9 — Introduction of Sulbactam-Durlobactam into Central Vein, Percutaneous Approach, New Technology Group 9, XW043PB — Introduction of Aztreonam-avibactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11, XW043WB — Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11, XW0DX38 — Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8, XW0G738 — Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8, XW0H738 — Introduction of Maribavir Anti-infective into Lower GI, Via Natural or Artificial Opening, New Technology Group 8, XW0U0GA — Introduction of Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System into Joints, Open Approach, New Technology Group 10, XW0V0P7 — Introduction of Gentamicin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7

Contextual Map

Every relationship of 3E05029 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

Clinical classification (CCSR)

Nearest codes

Change history

No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.

Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April); CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels